Question

Difficulty: MediumPharmacologic Interventions

A 5555-year-old male establishes care for hypertension management. His medical history is significant for bipolar I disorder and mild persistent asthma. His bipolar disorder has been well-controlled on lithium carbonate for the past eight years without recurrent mood episodes. His asthma is managed with an as-needed albuterol inhaler. Blood pressure readings from his past three clinic visits have consistently averaged 154/96154/96 mmHg, despite strict adherence to a low-sodium diet and a daily exercise regimen. Today, his blood pressure is 156/94156/94 mmHg, and his pulse is 7272/min. Physical examination reveals clear lungs bilaterally with no wheezing. Laboratory studies show a serum creatinine of 0.90.9 mg/dL, serum potassium of 4.24.2 mEq/L, and a serum lithium level of 0.80.8 mEq/L (therapeutic range: 0.60.6 to 1.21.2 mEq/L). The physician decides to initiate pharmacologic therapy for his hypertension. Which of the following is the most appropriate medication to prescribe for this patient?

  1. AmlodipineAnswer
  2. B
    Hydrochlorothiazide
  3. C
    Lisinopril
  4. D
    Propranolol
  5. E
    Valsartan

Answer

The correct answer is amlodipine, as it does not interact with lithium or exacerbate asthma.
The correct answer is amlodipine. This patient requires pharmacotherapy for newly diagnosed hypertension. He has two critical comorbidities to consider: bipolar disorder managed with lithium, and asthma. Lithium has a very narrow therapeutic index. Its clearance is exclusively renal and closely tied to sodium handling. Amlodipine is a dihydropyridine calcium channel blocker that effectively reduces blood pressure without clinically significant effects on renal lithium clearance. Furthermore, it does not act on beta-adrenergic receptors and is entirely safe for patients with asthma.

Step-by-Step Solution

1
Evaluate the patient's comorbidities and current medication list.
The patient requires antihypertensive therapy and concurrently has asthma (uses albuterol) and bipolar disorder (takes lithium).
Identifying existing conditions and medications is critical to prevent adverse drug events and dangerous drug-drug interactions when initiating new pharmacotherapy.
2
Identify contraindications and drug interactions for common antihypertensive classes.
Non-selective beta-blockers are contraindicated in asthma. Thiazide diuretics, ACE inhibitors, and ARBs significantly decrease renal lithium clearance.
Lithium has a narrow therapeutic index, and its renal excretion is highly dependent on sodium and fluid balance. Medications that alter proximal tubular sodium handling or glomerular filtration can quickly lead to lithium toxicity.
3
Select the safest antihypertensive agent that avoids these risks.
Amlodipine, a calcium channel blocker, is selected.
Calcium channel blockers do not significantly impact lithium levels and are safe for patients with reactive airway disease.

Key Concept

When treating hypertension in a patient taking lithium, thiazide diuretics, ACE inhibitors, and ARBs should generally be avoided because they decrease renal lithium clearance and increase the risk of toxicity. Calcium channel blockers are safe and preferred.
Rate this question